Differential regulation of luteinizing hormone, follicle-stimulating hormone, and free alpha-subunit secretion from the gonadotrope by gonadotropin-releasing hormone (GnRH): evidence from the use of two GnRH antagonists.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  1990-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/JCEM-70-2-328PMID 2105329
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men.

  1989cited by this paper
• Activin stimulates secretion of follicle-stimulating hormone from pituitary cells desensitized to gonadotropin-releasing hormone.

  1988cited by this paper
• Alpha-subunit secretion in men with idiopathic hypogonadotropic hypogonadism.

  1988cited by this paper
• Evidence of differential control of FSH and LH secretion by gonadotropin-releasing hormone (GnRH) from the use of a GnRH antagonist.

  1988cited by this paper
• Improved measurement of free alpha subunit of glycoprotein hormones by assay with use of a monoclonal antibody.

  1988cited by this paper
• Pulsatile follicle-stimulating hormone secretion is independent of luteinizing hormone-releasing hormone (LHRH): pulsatile replacement of LHRH bioactivity in LHRH-immunoneutralized rats.

  1987cited by this paper
• Administration of low dose pulsatile gonadotropin-releasing hormone (GnRH) to GnRH-deficient men regulates free alpha-subunit secretion.

  1986cited by this paper
• Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid

  1986cited by this paper
• The changing ratio of serum bioactive to immunoreactive follicle-stimulating hormone in normal men following treatment with a potent gonadotropin releasing hormone antagonist.

  1986cited by this paper
• Evidence that pulsatile follicle-stimulating hormone secretion is independent of endogenous luteinizing hormone-releasing hormone.

  1986cited by this paper
• Suppression of follicular development after chronic LHRH immunoneutralization in the ewe.

  1986cited by this paper
• Characterization of the physiological pattern of episodic gonadotropin secretion throughout the human menstrual cycle.

  1986cited by this paper
• Pulsatile secretion of thyrotropin in man.

  1986cited by this paper
• New effective gonadotropin releasing hormone antagonists with minimal potency for histamine release in vitro.

  1986cited by this paper
• Differential suppression of follicle-stimulating hormone and luteinizing hormone secretion in vivo by a gonadotropin-releasing hormone antagonist.

  1985cited by this paper
• Pulsatile secretion of immunoreactive alpha-subunit in man.

  1985cited by this paper
• Differential hypothalamic control of FSH secretion: a review.

  1983cited by this paper
• The biologic activity of a potent analogue of gonadotropin-releasing hormone in normal and hypogonadotropic men.

  1980cited by this paper
• Blockade of episodic secretion of luteinizing hormone in the ram by the administration of antibodies to luteinizing hormone releasing hormone.

  1979cited by this paper
• THYROID HORMONE, OESTROGEN, AND GLUCOCORTICOID EFFECTS ON TWO DIFFERENT PITUITARY GLYCOPROTEIN HORMONE ALPHA SUBUNIT POOLS

  1978cited by this paper
• Pituitary secretion of free alpha and beta subunit of human thyrotropin in patients with thyroid disorders.

  1975cited by this paper
• Ihibition of the pre-ovulatory proestrous gonadotropin surge, ovulation and pregnancy with a peptide analogue of luteinizing hormone releasing hormone.

  1975cited by this paper

• Comparison of the neonatal outcomes of progestin-primed ovarian stimulation and flexible GnRH antagonist protocols: a propensity score–matched cohort study

  2023cites this paper
• Comparison Of Biochemical Markers and Insulin Resistance of Polycystic Ovary Syndrome Patients Diagnosed with the Criteria of Rotterdam, Androgen Excess Society and National Institutes of Health

  2023cites this paper
• Comparison of the Cumulative Live Birth Rates of Progestin-Primed Ovarian Stimulation and Flexible GnRH Antagonist Protocols in Patients With Low Prognosis

  2021cites this paper
• Neuroendocrinology of Reproduction

  2021cites this paper
• Comparison of Cumulative Live Birth Rates Per Aspiration IVF/ICSI Cycle Between GnRH Antagonist Protocol and Progesterone-Primed Ovarian Stimulation Protocol for Infertility With Normal Ovarian Reserve: A Randomised Controlled Trial

  2021cites this paper
• Development of the induced gonadotropin surge mechanism in the prepubertal heifer

  2020cites this paper
• Neuroendocrine Control of the Menstrual Cycle

  2019cites this paper
• CUTANEOUS MANIFESTATIONS OF POLYCYSTIC OVARIAN DISEASE

  2018cites this paper
• Modeling associations between latent event processes governing time series of pulsing hormones

  2018cites this paper
• A new fully human recombinant FSH (follitropin epsilon): two phase I randomized placebo and comparator-controlled pharmacokinetic and pharmacodynamic trials

  2017influential citation
• Aging and Reproduction

  2015cites this paper
• Control of the Menstrual Cycle

  2015cites this paper
• Chapter 8 – Neuroendocrine Control of the Menstrual Cycle

  2014cites this paper
• Absence of circadian rhythms of gonadotropin secretion in women.

  2011cites this paper
• Hormonal manipula t ions in t he lu t eal phase

  2011cites this paper
• Polycystic Ovary Syndrome

  2010cites this paper
• Ovarian aging: mechanisms and clinical consequences.

  2009cites this paper
• CHAPTER 7 – Neuroendocrine Control of the Menstrual Cycle

  2009cites this paper
• Aging in the Hypothalamic-Pituitary-Ovarian Axis

  2006cites this paper
• CHAPTER 45 – Control of Follicular Development, Corpus Luteum Function, the Maternal Recognition of Pregnancy, and the Neuroendocrine Regulation of the Menstrual Cycle in Higher Primates

  2006cites this paper
• Absence of Apparent Circadian Rhythms of Gonadotropins and Free α-Subunit in Postmenopausal Women: Evidence for Distinct Regulation Relative to Other Hormonal Rhythms

  2006cites this paper
• Coordination of Antral Follicle Growth: Basis for Innovative Concepts of Controlled Ovarian Hyperstimulation

  2005cites this paper
• Coordination of antral follicle growth: basis for innovative concepts of controlled ovarian hyperstimulation.

  2005cites this paper
• Hormonal manipulations in the luteal phase to coordinate subsequent antral follicle growth during ovarian stimulation.

  2005cites this paper
• Pharmacokinetics and Pharmacodynamics of a Novel Depot Formulation of Abarelix, a Gonadotropin‐Releasing Hormone (GnRH) Antagonist, in Healthy Men Ages 50 to 75

  2004cites this paper
• Premenstrual administration of gonadotropin-releasing hormone antagonist coordinates early antral follicle sizes and sets up the basis for an innovative concept of controlled ovarian hyperstimulation.

  2004cites this paper
• Pharmacokinetics and pharmacodynamics of abarelix, a gonadotropin‐releasing hormone antagonist, after subcutaneous continuous infusion in patients with prostate cancer

  2003cites this paper
• Effectiveness of an antagonist to gonadotrophin releasing hormone on the FSH and LH response to GnRH in perifused equine pituitary cells, and in seasonally acyclic mares.

  2002cites this paper
• Evidence that GnRH decreases with gonadal steroid feedback but increases with age in postmenopausal women.

  2002cites this paper
• Die gestörte Gonadotropinsekretion beim Syndrom der polyzystischen Ovarien (PCOS) und Erklärungsmodelle aus In-vitro-Experimenten

  2002cites this paper
• Is there an FSH-releasing factor?

  2001cites this paper
• Neuroendocrine aspects of aging in women.

  2001cites this paper
• Temporal coupling of luteinizing hormone and follicle stimulating hormone secretion in polycystic ovary syndrome

  2001cites this paper
• Pharmacodynamic effects and plasma pharmacokinetics of single doses of cetrorelix acetate in healthy premenopausal women.

  2001cites this paper
• Neuroendocrine vs. paracrine control of follicle-stimulating hormone.

  2001cites this paper
• Effect of the Concurrent LHRH Antagonist Administration with a LHRH Superagonist in Rats

  2000cites this paper
• Local tolerance, pharmacokinetics, and dynamics of ganirelix (Orgalutran) administration by Medi-Jector compared to conventional needle injections.

  2000cites this paper
• Measurement of Plasma Free Luteinizing Hormoneβ -Subunit in Women

  2000cites this paper
• Decrease in gonadotropin-releasing hormone (GnRH) pulse frequency with aging in postmenopausal women.

  2000cites this paper
• Gonadotropin-releasing hormone antagonists

  2000cites this paper
• Measurement of plasma free luteinizing hormone beta-subunit in women.

  2000cites this paper
• Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon/Orgalutran ∗ ). part II. dose-proportionality and gonadotropin suppression after multiple doses of ganirelix in healthy female volunteers

  1999cites this paper
• Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon/Orgalutran). Part II. Dose-proportionality and gonadotropin suppression after multiple doses of ganirelix in healthy female volunteers.

  1999cites this paper
• Free alpha-subunit is superior to luteinizing hormone as a marker of gonadotropin-releasing hormone despite desensitization at fast pulse frequencies.

  1999cites this paper
• Inhibin A and inhibin B responses to gonadotropin withdrawal depends on stage of follicle development.

  1999cites this paper
• Pituitary glycoprotein hormone a-subunit secretion by cirrhotic patients.

  1999cites this paper
• Recent insights into neuroendocrine mechanisms of aging of the human male hypothalamic-pituitary-gonadal axis.

  1999cites this paper
• Gonadotropin-releasing hormone deficiency in the human (idiopathic hypogonadotropic hypogonadism and Kallmann's syndrome): pathophysiological and genetic considerations.

  1998cites this paper
• Hypogonadotropic hypogonadism.

  1998cites this paper
• Exaggerated Free α-Subunit Levels during Pulsatile Gonadotropin-Releasing Hormone Replacement in Women with Idiopathic Hypogonadotropic Hypogonadism1

  1998cites this paper
• Single and multiple dose pharmacokinetics and pharmacodynamics of the gonadotrophin-releasing hormone antagonist Cetrorelix in healthy female volunteers.

  1998cites this paper
• Use of a gonadotropin-releasing hormone antagonist as a physiologic probe in polycystic ovary syndrome: assessment of neuroendocrine and androgen dynamics.

  1998cites this paper
• Exaggerated free alpha-subunit levels during pulsatile gonadotropin-releasing hormone replacement in women with idiopathic hypogonadotropic hypogonadism.

  1998cites this paper
• Lactation inhibits the potentiating effect of galanin upon the GnRH-induced LH release observed in diestrous-1 rat.

  1998cites this paper
• Gonadotropin Deficiency: Differential Diagnosis and Treatment

  1997cites this paper
• Twenty-four-hour profiles of luteinizing hormone, follicle-stimulating hormone, testosterone, and estradiol levels: a semilongitudinal study throughout puberty in healthy boys.

  1997cites this paper
• A novel approach to assess changes in endocrine secretion: analysis of GnRH antagonist (Nal-Glu) suppression of gonadotropin release in ovariectomized ewes.

  1997cites this paper
• Neuroendocrine control of follicle-stimulating hormone (FSH) secretion. I. Direct evidence for separate episodic and basal components of FSH secretion.

  1997cites this paper
• Diseases of the Pituitary

  1997cites this paper
• Neuroendocrine Control of Follicle-Stimulating Hormone (FSH) Secretion. I. Direct Evidence for Separate Episodic and Basal Components of FSH Secretion1.

  1997cites this paper
• Neuroendocrinology of the polycystic ovary syndrome.

  1996cites this paper
• Short term pituitary desensitization: effects of different doses of the gonadotrophin-releasing hormone agonist triptorelin.

  1996cites this paper
• Hypothalamic-Pituitary Dynamics in Polycystic Ovary Syndrome

  1996cites this paper
• Short term pituitary desensitization: effects of different doses of the gonadotrophin-releasing hormone agonist triptorelin

  1996cites this paper
• Evaluation of the impact of concurrent gonadotropin-releasing hormone (GnRH) antagonist administration on GnRH agonist-induced gonadotrope desensitization.

  1995cites this paper
• Suppression of follicular phase pituitary-gonadal function by a potent new gonadotropin-releasing hormone antagonist with reduced histamine-releasing properties (ganirelix).

  1995cites this paper
• Defective regulation of glycoprotein free alpha-subunit in males with isolated gonadotropin-releasing hormone deficiency--a clinical research center study.

  1995cites this paper
• Midcycle levels of sex steroids are sufficient to recreate the follicle-stimulating hormone but not the luteinizing hormone midcycle surge: evidence for the contribution of other ovarian factors to the surge in normal women.

  1995cites this paper
• Development and applications of luteinizing hormone-releasing hormone antagonists in the treatment of infertility: an overview.

  1995cites this paper
• Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion.

  1995cites this paper
• Decreased release of gonadotropin-releasing hormone during the preovulatory midcycle luteinizing hormone surge in normal women.

  1994cites this paper
• Comparative effects of two different delivery systems on gonadotropin-releasing hormone (GnRH) antagonist-induced suppression of gonadotropins and testosterone in man.

  1994cites this paper
• Contrasting effects of a gonadotropin-releasing hormone agonist and antagonist on the secretion of free alpha subunit.

  1994cites this paper
• The midcycle gonadotropin surge in normal women occurs in the face of an unchanging gonadotropin-releasing hormone pulse frequency.

  1994cites this paper
• Rapid regression of uterine leiomyomas in response to daily administration of gonadotropin-releasing hormone antagonist.

  1994cites this paper
• Use of the Free Alpha Subunit (FAS) of Glycoprotein Secreting Hormones as a Surrogate Marker of GnRH Secretion in the Human

  1994cites this paper
• Influence of the ovary on parameters of LH secretion during the recovery from buserelin-induced desensitization.

  1994cites this paper
• Control of the preovulatory Luteinizing Hormone surge by Gonadotropin-Releasing Hormone antagonists: prospects for clinical application.

  1994cites this paper
• Seven-day administration of the gonadotropin-releasing hormone antagonist Cetrorelix in normal cycling women.

  1994cites this paper
• Reproductive hormone genes in mothers of spontaneous dizygotic twins: an association study

  1993cites this paper
• New Approaches to the Study of the Neuroendocrine Abnormalities of Women with the Polycystic Ovarian Syndrome a

  1993cites this paper
• Rapid regression of uterine leiomyomas in response to daily administration of gonadotropin-releasing hormone antagonist * †

  1993cites this paper
• Gonadotropin-Releasing Hormone Antagonists: Effects on the Ovarian Follicle and Corpus Luteum

  1993cites this paper
• Effective suppression of luteinizing hormone and testosterone by single doses of the new gonadotropin-releasing hormone antagonist cetrorelix (SB-75) in normal men.

  1992cites this paper
• Concordant suppression of serum immunoreactive luteinizing hormone (LH), follicle-stimulating hormone, alpha subunit, bioactive LH, and testosterone in postmenopausal women by a potent gonadotropin releasing hormone antagonist (detirelix).

  1992cites this paper
• LH-RH antagonists: state of the art and future perspectives.

  1992cites this paper
• Peptides in Oncology I

  1992cites this paper
• Use of GnRH Antagonists as Physiologic Probes in the Female

  1992cites this paper
• An Overview of GnRH Antagonist Development: Two Decades of Progress

  1992cites this paper
• Endocrine effects and pharmacokinetic characteristics of a potent new gonadotropin-releasing hormone antagonist (Ganirelix) with minimal histamine-releasing properties: studies in postmenopausal women.

  1992cites this paper
• Exogenous gonadotrophin-releasing hormone (GnRH) stimulates LH secretion in male monkeys (Macaca fascicularis) treated chronically with high doses of a GnRH antagonist.

  1992cites this paper
• Effect of improved assay sensitivity on luteinizing hormone pulse detection after gonadotropin-releasing hormone antagonist treatment in man.

  1992cites this paper
• Variable tolerance of the developing follicle and corpus luteum to gonadotropin-releasing hormone antagonist-induced gonadotropin withdrawal in the human.

  1991cites this paper
• Effects of gonadotrophin releasing hormone antagonist and agonist on the pulsatile release of gonadotrophins and α‐subunit in postmenopausal women *

  1991influential citation
• Gonadotropin and Free α-Subunit Secretion in Patients During GnRH-Agonist Treatment

  1991cites this paper
• Gonadotropin and free alpha-subunit secretion in patients during GnRH-agonist treatment.

  1991cites this paper
• Inhibition of follicular development by a potent antagonistic analog of gonadotropin-releasing hormone (detirelix).

  1991cites this paper
• Altered patterns of pituitary secretion and renal excretion of free alpha-subunit during gonadotropin-releasing hormone agonist-induced pituitary desensitization.

  1991cites this paper
• Follicular arrest during the midfollicular phase of the menstrual cycle: a gonadotropin-releasing hormone antagonist imposed follicular-follicular transition.

  1991cites this paper
• Neuroendocrine abnormalities in patients with traumatic brain injury.

  1991cites this paper